We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Phosphorylation is the Key to Cyst Formation in Toxoplasma

By Biotechdaily staff writers
Posted on 30 Jun 2008
Molecular parasitologists have identified the mechanism used by the protozoan parasite Toxoplasma gondii to transform into protective cysts that resist destruction by the immune system.

A key problem in the treatment of numerous pathogenic eukaryotes centers on their development into latent forms during stress. In a study published in the June 13, 2008, issue of the Journal of Biological Chemistry, investigators at the Indiana University School of Medicine (Indianapolis, USA) traced the mechanism used by the parasite T. gondii to transform into cysts and remain in this state.

They found that the Toxoplasma eukaryotic initiation factor-2-alpha (TgIF2-alpha) was phosphorylated during stress, which induced the parasite to transform into cysts. In addition, they characterized novel eIF2 kinases, one in the endoplasmic reticulum and a likely regulator of the unfolded protein response (TgIF2K-A) and another that is a probable responder to cytoplasmic stresses (TgIF2K-B). These findings suggest that eIF2-alpha phosphorylation is employed by cells to maintain a latent state.

"We found a cellular signal that appears to put the parasite to sleep, which in turn tells us something new about how opportunistic pathogens such as Toxoplasma awaken to cause disease during immunosuppression,” said senior author Dr. William J. Sullivan, assistant professor of pharmacology and toxicology at the Indiana University School of Medicine. "A healthy immune system can keep this parasite in the cyst state. Without a healthy immune system, this organism can run rampant. This can be a very serious problem for people with AIDS.”


Related Links:
Indiana University School of Medicine

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Portable POCT Blood Gas Analyzer
BD100

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
30 Jun 2008  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
30 Jun 2008  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
30 Jun 2008  |   BioResearch